Answer
Yes, nausea and headache are common side effects of dalbavancin in adults, occurring in 2.4% and 1.3% of treated patients respectively in Phase 2/3 studies, and were generally mild or moderate.
Sources for this answer
- Xydalba 500 mg powder for concentrate for solution for infusionADVANZ Pharma · emc · SmPC §4.8 Undesirable effects · Version 8Document updated
Sources checked